This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-04-24 BR&R Conf Call"
Jump to navigation
Jump to search
| (16 intermediate revisions by 2 users not shown) | |||
| Line 21: | Line 21: | ||
=Attendees= | =Attendees= | ||
| − | * Boris | + | * Boris Brodsky (Co-chair) |
| − | * Ed Helton ( | + | * Ed Helton (Co-chair) |
| − | * Hugh Glover ( | + | * Hugh Glover (Co-chair) |
| − | * Myron Finseth ( | + | * Myron Finseth (Co-chair) |
| + | * Julia Chen | ||
| + | * Jean Duteau | ||
| + | * Julie Evans | ||
| + | * Bill Friggle | ||
| + | * Norman Gregory | ||
| + | * Bill Gregory | ||
| + | * Smita Hastak | ||
| + | * Wendy Ver Hoef | ||
| + | * Ulli Wagner | ||
| + | * Catherine Hosage Norman | ||
| + | * Robinette Renner | ||
| + | * Jane Pollack | ||
| + | * Panagiotis Telonis | ||
=Agenda Items and notes= | =Agenda Items and notes= | ||
| − | == | + | ==Minutes Approval== |
* Approve minutes from conference call on April 10th | * Approve minutes from conference call on April 10th | ||
| + | * Motion to approve (Julie E), second (Jean), approved | ||
| − | === | + | ==FHIR== |
| − | |||
| − | === | + | ===IDMP Substance Resource=== |
| − | * PSS | + | * Background on the IDMP Substance activities (Panagiotis) |
| + | * PSS review (Boris) | ||
| + | * Motion to approve (Hugh), second (Smita), abstentions (Bill G), approved. | ||
| + | * '''Action:''' Updated PSS to be shared with the listserve. | ||
| − | === | + | ===Lab model (in collaboration with TCB)=== |
| − | |||
* Report back from last meeting (Julie E) | * Report back from last meeting (Julie E) | ||
| + | * Group to make changes in FHIR regarding the Lab Model, minutes at [[http://wiki.hl7.org/images/f/f6/TCB_Lab_Model_to_FHIR_Team_Meeting_18_April_2018.pdf]] | ||
| + | * Will be planning for September Connectathon at the WGM | ||
| − | === | + | ===AE Model=== |
* FDA use cases (Boris) | * FDA use cases (Boris) | ||
| + | * 1) Sponsors and investigators exchanging FHIR AE messages (pre-market) | ||
| + | * 2) Healthcare professionals submitting voluntary safety reports via FHIR AE messages | ||
| + | * Patient Care (PC) WG is the present custodian of the FHIR AE resource, proposed to maintain since PC is central to the regulatory use cases | ||
| + | * PC will be working to progress the resource to the level of Maturity past 0. | ||
| + | * PC having a discussion of AE resource with FDA to understand the FDA requirements against the present AE resource | ||
| + | * '''Action:''' BR&R representatives to attend PC WG meeting on Thu Q3 to discuss | ||
| − | === | + | ===FHIR Tracker Items=== |
| − | * | + | * Concern with de-identification of subject data, as the ResearchSubject resource is linked to the identifiable Patient resource (Hugo) |
| + | See 6.0.5.8 De-Identification, pseudonymization, anonymization for FHIR [[https://build.fhir.org/secpriv-module.html#deId]] (Julia) | ||
| + | * '''Action:''' Set up a call with Hugo, Hugh, and Julie. Hugo will create and share a sample scenario ahead of the call (Hugh?) | ||
| − | === | + | ===Connectathon=== |
| − | * [http://wiki.hl7.org/index.php?title=201805_Clinical_Research_Track Connectathon activity in Cologne] | + | * [[http://wiki.hl7.org/index.php?title=201805_Clinical_Research_Track Connectathon activity in Cologne]] |
| − | === | + | ==May WGM Agenda== |
| − | * | + | * Draft is at [[http://wiki.hl7.org/index.php?title=Wc_2018-05-14_BR%26R_WG_Meeting]] |
| − | + | * '''Action:''' Make changes reflected in the updated WGM agenda on the Wiki: | |
| − | + | * - Move BRIDG Rearchitecture from Mon Q4 to Tue Q3 | |
| − | * | + | * - Put IDMP Substance to Tue Q1 |
| − | + | * - Make Tue Q4 open (overtaken by Thu Q3) | |
| + | * - Wed Q3 – don’t need the entire quarter (leave part as a placeholder) | ||
| + | * - Thu Q2: Clarify that Jeff Lowe will speak on the Sept Connectathon topics relevant to BR&R | ||
Latest revision as of 15:50, 11 May 2018
|
Related Links |
Attendees
- Boris Brodsky (Co-chair)
- Ed Helton (Co-chair)
- Hugh Glover (Co-chair)
- Myron Finseth (Co-chair)
- Julia Chen
- Jean Duteau
- Julie Evans
- Bill Friggle
- Norman Gregory
- Bill Gregory
- Smita Hastak
- Wendy Ver Hoef
- Ulli Wagner
- Catherine Hosage Norman
- Robinette Renner
- Jane Pollack
- Panagiotis Telonis
Agenda Items and notes
Minutes Approval
- Approve minutes from conference call on April 10th
- Motion to approve (Julie E), second (Jean), approved
FHIR
IDMP Substance Resource
- Background on the IDMP Substance activities (Panagiotis)
- PSS review (Boris)
- Motion to approve (Hugh), second (Smita), abstentions (Bill G), approved.
- Action: Updated PSS to be shared with the listserve.
Lab model (in collaboration with TCB)
- Report back from last meeting (Julie E)
- Group to make changes in FHIR regarding the Lab Model, minutes at [[1]]
- Will be planning for September Connectathon at the WGM
AE Model
- FDA use cases (Boris)
- 1) Sponsors and investigators exchanging FHIR AE messages (pre-market)
- 2) Healthcare professionals submitting voluntary safety reports via FHIR AE messages
- Patient Care (PC) WG is the present custodian of the FHIR AE resource, proposed to maintain since PC is central to the regulatory use cases
- PC will be working to progress the resource to the level of Maturity past 0.
- PC having a discussion of AE resource with FDA to understand the FDA requirements against the present AE resource
- Action: BR&R representatives to attend PC WG meeting on Thu Q3 to discuss
FHIR Tracker Items
- Concern with de-identification of subject data, as the ResearchSubject resource is linked to the identifiable Patient resource (Hugo)
See 6.0.5.8 De-Identification, pseudonymization, anonymization for FHIR [[2]] (Julia)
- Action: Set up a call with Hugo, Hugh, and Julie. Hugo will create and share a sample scenario ahead of the call (Hugh?)
Connectathon
May WGM Agenda
- Draft is at [[3]]
- Action: Make changes reflected in the updated WGM agenda on the Wiki:
- - Move BRIDG Rearchitecture from Mon Q4 to Tue Q3
- - Put IDMP Substance to Tue Q1
- - Make Tue Q4 open (overtaken by Thu Q3)
- - Wed Q3 – don’t need the entire quarter (leave part as a placeholder)
- - Thu Q2: Clarify that Jeff Lowe will speak on the Sept Connectathon topics relevant to BR&R
